Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review
- 1 January 2025
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 9 (9) , e2400305
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyThe Lancet Oncology, 2023
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal CancerNew England Journal of Medicine, 2020
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsThe Lancet Oncology, 2020
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trialsThe Lancet Oncology, 2020
- NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 casesLaboratory Investigation, 2019
- Molecular characterization of cancers with NTRK gene fusionsLaboratory Investigation, 2019
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenNew England Journal of Medicine, 2018
- Resistance to checkpoint blockade therapy through inactivation of antigen presentationNature Communications, 2017
- Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinomaCancer Letters, 2015
- Neurotrophins and their receptors: A convergence point for many signalling pathwaysNature Reviews Neuroscience, 2003